Stock Events

Stock Events

Senseonics 

0
435
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 9Expected
Q1 2026
Q2 2026
Next
-0.61
-0.56
-0.51
-0.46
Expected EPS
-0.46326031500000003
Actual EPS
N/A

Financials

-196.47%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
30.47MRevenue
-59.87MNet Income

Analyst Ratings

$10.81Average Price Target
The highest estimate is ⁦13.66⁩.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6L6.STU. It's not an investment recommendation.
Tesla
67
TSLA
Apple
66
AAPL
Palantir Technologies
60
PLTR
Amazon
57
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap30.69B
Dexcom produces continuous glucose monitoring systems for diabetes management, directly competing with Senseonics' Eversense CGM system.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers the FreeStyle Libre, a flash glucose monitoring system, competing in the glucose monitoring space.
Tandem Diabetes Care
TNDM
Mkt Cap1.33B
Tandem Diabetes Care manufactures insulin pumps and integrated diabetes management systems, competing in the broader diabetes management market.
Insulet
PODD
Mkt Cap10.38B
Insulet Corporation develops the Omnipod, an insulin management system, which competes with diabetes management solutions like Senseonics'.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers the Guardian Sensor 3 CGM and insulin pumps, providing integrated diabetes management solutions.
Mirum Pharmaceuticals
MIRM
Mkt Cap5.52B
Mirum Pharmaceuticals, though more focused on liver diseases, has interests in metabolic disorders, potentially overlapping with diabetes management.
Novo Nordisk
NVO
Mkt Cap176.43B
Novo Nordisk specializes in diabetes care with insulin and GLP-1 receptor agonists, indirectly competing in diabetes management.
Sanofi
SNY
Mkt Cap106.24B
Sanofi produces insulin and other diabetes medications, competing in the broader market for diabetes management.
Merck
MRK
Mkt Cap368.89B
Merck & Co., with its diabetes medication portfolio, including Glucophage, competes in the pharmaceutical management of diabetes.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol-Myers Squibb, through its metabolic disorders treatment portfolio, indirectly competes in the diabetes management space.

About

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
Show More
CEO
Timothy T. Goodnow
Employees
130
Country
United States
ISIN
US81727U1051
WKN
000A41MRZ

Listings

MU
DE
6L60.MU
F
DE
6L60.F
MU
DE
6L6.MU
STU
DE
6L60.STU

0 Comments

Share your thoughts

FAQs

What is Senseonics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Senseonics stocks are traded under the ticker 6L6.STU.
When is the next Senseonics earnings date?▼
Senseonics is going to release the next earnings report on November 9, 2026.
What were Senseonics earnings last quarter?▼
6L6.STU earnings for the last quarter are -0.55 EUR per share, whereas the estimation was -0.53 EUR resulting in a -2.84% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Senseonics revenue for the last year?▼
Senseonics revenue for the last year amounts to 30.47M EUR.
What is Senseonics net income for the last year?▼
6L6.STU net income for the last year is -59.87M EUR.
How many employees does Senseonics have?▼
As of November 7, 2026, the company has 130 employees.
In which sector is Senseonics located?▼
Senseonics operates in the Health & Wellness sector.
When did Senseonics complete a stock split?▼
The last stock split for Senseonics was on October 20, 2025 with a ratio of 1:20.
Where is Senseonics headquartered?▼
Senseonics is headquartered in GERMANTOWN, United States.